Radiation therapy (RT), a major modality for treating localized tumors, can induce tumor regression outside the radiation field through an abscopal effect that is thought to involve the immune system. Our studies were designed to understand the early immunological effects of RT in the tumor microenvironment using several syngeneic mouse tumor models. We observed that RT induced sterile inflammation with a rapid and transient infiltration of CD11b + Gr-1 high+ neutrophils into the tumors. RT-recruited tumor-associated neutrophils (RT-Ns) exhibited an increased production of reactive oxygen species and induced apoptosis of tumor cells. Tumor infiltration of RT-Ns resulted in sterile inflammation and, eventually, the activation of tumor-specific cytotoxic T cells, their recruitment into the tumor site, and tumor regression. Finally, the concurrent administration of granulocyte colony-stimulating factor (G-CSF) enhanced RT-mediated antitumor activity by activating RT-Ns. Our results suggest that the combination of RT and G-CSF should be further evaluated in preclinical and clinical settings.
Radiation therapy (RT), a major modality for treating localized tumors, can induce tumor regression outside the radiation field through an abscopal effect that is thought to involve the immune system. Our studies were designed to understand the early immunological effects of RT in the tumor microenvironment using several syngeneic mouse tumor models. We observed that RT induced sterile inflammation with a rapid and transient infiltration of CD11b + Gr-1 high+ neutrophils into the tumors. RT-recruited tumor-associated neutrophils (RT-Ns) exhibited an increased production of reactive oxygen species and induced apoptosis of tumor cells. Tumor infiltration of RT-Ns resulted in sterile inflammation and, eventually, the activation of tumor-specific cytotoxic T cells, their recruitment into the tumor site, and tumor regression. Finally, the concurrent administration of granulocyte colony-stimulating factor (G-CSF) enhanced RT-mediated antitumor activity by activating RT-Ns. Our results suggest that the combination of RT and G-CSF should be further evaluated in preclinical and clinical settings.
radiation therapy | tumor-associated neutrophils | G-CSF R adiation therapy (RT) is one of the three core modalities for the treatment of cancer, although tumor recurrence is observed even with high doses of fractionated stereotactic RT (1) . Recent studies have shown that RT-induced tumor cell death is "immunogenic" and that RT generates antitumor immune responses, including cytotoxic T lymphocytes (CTLs) (2) , the main effectors against tumor cells (3) .
Tumor-associated neutrophils (TANs) can have both anti-and protumor effects (4) (5) (6) . As in the case of tumor-associated macrophages, where alternative polarization pathways (M1 versus M2) are involved, a paradigm of antitumor "N1 neutrophils" versus protumor "N2 neutrophils" has been proposed using mouse tumor models (7) in which TGF-β blocked the switch from the "N2" to the "N1" antitumorigenic phenotype. It has been demonstrated that tumors grow faster in the absence of endogenous IFN-β because antitumor N1 TANs are not induced (5, 8) . In addition, neovascularization increased numbers of infiltrating N2 TANs expressing higher levels of CXCR4 and vascular endothelial growth factor (VEGF) were observed (5, 8) . In a clinical study conducted in surgically resected patients with early-stage lung cancer, it has been demonstrated that TANs are not immunosuppressive but, instead, stimulate T-cell responses (9) . Thus, the role of TANs in tumor immunology and the conditions triggering anti-and protumor polarization are still not fully understood.
Sterile inflammation occurs in the absence of pathogens following tissue damage (10, 11) . The hallmark of sterile inflammation is the rapid infiltration of neutrophils, as is also observed in the spleen, thymus, and gut after whole-body ionizing radiation in mice (12) (13) (14) . Inflammatory responses, known as damage-associated molecular patterns (DAMPs), which are released from dying cells, are initiated by endogenous molecules (10, 15, 16) . DAMPs activate sentinel cells to release proinflammatory mediators (e.g., IL-1β, TNF) and neutrophil-active chemoattractants [e.g., MIP-2, SDF-1, RANTES, chemokine receptor CXCR2 ligand (KC), IL-8, LTB4] (11, 17) , initiating the recruitment of neutrophils into the tissue.
This study reports neutrophil-mediated sterile inflammation as a result of RT of tumors. We demonstrate a rapid and transient infiltration of TANs after local irradiation [RT-recruited TANs (RT-Ns)]. RT alone or in combination with granulocyte colonystimulating factor (G-CSF) induces the polarization of antitumor N1 (RT-Ns), which produce reactive oxygen species (ROS). (18) , we isolated them from syngeneic tumor grafts of both irradiated (15 Gy) and nonirradiated tumors of RM-9-bearing C57BL/6 mice using flow cytometry, and observed a neutrophil-like morphology (Fig. 1A) .
Results

CD11b
To examine the infiltration of TANs after focal irradiation, flow cytometric analysis was performed on cells obtained from syngeneic tumor grafts of RM-9-bearing C57BL/6, 4T1-bearing BALB/c, and EG7-bearing C57BL/6 mice between 0 and 96 h after 15 Gy, 15 Gy, and 1.3 Gy of focused irradiation, respectively. Differences in optimal radiation doses between RM-9, 4T1, and EG7 tumors were due to their varying radiosensitivities (Fig. S1 ).
An increase in CD11b + Gr-1 high+ cells infiltrating RM-9 (from 18.4 to 26.7%), 4T1 (from 26.1 to 42.7%), and EG7 (from 4.9 to 9.0%) tumors was observed 24 h after tumor irradiation (Fig. 1A and Fig. S2 A and B) . In all tumor models, the TANs within the lymphocyte and granulocyte populations began to increase at 12 h after an initial transient decrease at 6 h, peaked at 24 h, and steadily declined thereafter (Fig. 1B and Fig. S2 A and B) . Although the initial decrease is likely due to radiation, the results
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The authors declare no conflict of interest. demonstrate that this transient decrease is followed by an early RT-mediated infiltration of TANs.
RT-Ns Inhibit Tumor Growth Following Focal Irradiation. Neutrophildepleted mice were used to ascertain the effect of TANs recruited into the tumors following RT (RT-Ns). To deplete neutrophils, mice were treated with an anti-Ly-6G monoclonal antibody [mAb; clone 1A8 as previously described (19) ]. We previously used the anti-Ly-6G mAb and confirmed that CD11b + Ly-6G + and CD11b + Gr-1 high+ cells (TANs) are equivalent (Fig. S3 ). We also observed that a single intraperitoneal (i.p.) injection of anti-Ly-6G mAb induced the complete depletion of TANs (Fig. S4 ) for up to 7 d (Fig. S5) .
We next evaluated the antitumor effect of RT in neutrophildepleted mice using the RM-9, 4T1, and EG7 tumor models after 15 Gy, 15 Gy, and 1.3 Gy of focused irradiation, respectively. RT and antibody therapy were as follows: (i) rat isotype IgG control, (ii) anti-Ly-6G mAb, (iii) RT + rat isotype IgG control, and (iv) RT + anti-Ly-6G mAb. Antibodies were injected 1 d before RT to ensure neutrophil depletion during RT. As shown in Fig. 2 and Fig. S6 A and B, no difference in growth was observed in the tumors in the absence of RT. However, a significant increase in tumor growth was observed following neutrophil depletion compared to tumor growth after RT. These observations suggest that RT-Ns play an important role in the antitumor activity of RT.
ROS Produced by RT-Ns Are Essential for the Antitumor Activity of RT. We next examined the differences between RT-Ns and CD11b + Gr-1 high+ neutrophils in nonirradiated tumors (ControlNs) using RM-9-and 4T1 tumor-bearing mice. To evaluate ROS production, TANs in cell suspensions from tumor homogenates were stimulated with N-formyl-L-methionyl-L-leucyl-phenylalanine (formyl peptide receptor 1 ligand) and the gated CD11b + Gr-1 high+ cells were analyzed by flow cytometry. We observed a significant increase in ROS production by RT-Ns compared with ROS production by Control-Ns in both tumor models ( Fig. 3A and Fig. S7 ). These results demonstrate that the RT-Ns were specifically activated.
To determine whether the observed antitumor effect of RT-Ns was ROS-mediated, we used the NADPH oxidase inhibitor diphenyleneiodonium (DPI) to inhibit ROS production (20, 21) . DPI was administered i.p. to mice 5 min after tumor irradiation when the effect of the RT-induced ROS effect was complete (the lifetime of ROS in a cell is a few nanoseconds) (22, 23) .
Local RT of RM-9 tumor-bearing mice caused significant inhibition of tumor growth compared with untreated mice (Fig.  3B ). However, administration of DPI into tumor-bearing mice reversed the inhibition of RT-mediated inhibition of tumor growth as effectively as the anti-Ly-6G mAb. These results demonstrate that the enhancement of RT antitumor activity by RT-Ns is ROS-mediated.
RT-Ns Induce Oxidative Damage and Apoptosis of Tumor Cells. ROS react with the plasma membrane, functional proteins, and nucleic acids, leading to oxidative damage and cell death (24) . We assessed oxidative damage and apoptosis in RM-9 tumor tissues by immunohistochemical analysis using mAbs against the oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (4-HNE) and the flow cytometric analysis of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay (24) .
As shown in Fig. 4 
A-D).
A similar trend was found in the TUNEL assay, with a significant increase of apoptotic cells in irradiated tumors compared with nonirradiated tumors. This phenomenon was abolished when the irradiated mice were neutrophil-depleted ( Fig. 4 E and F). The observed trends in oxidative damage and apoptosis are consistent with the difference in tumor size between normal and neutrophil-depleted mice ( Fig. 2A ). Taken together, these results suggest that the ROS produced by RT-Ns are likely responsible for oxidative damage and apoptosis of tumors, leading to the enhanced therapeutic effect of RT.
Cytokine and Chemokine Levels in Tumors Are Increased After
Irradiation. To investigate the mechanism involved in the recruitment of neutrophils into tumor tissue following irradiation, changes in chemokines and cytokines involved in the recruitment and activation of neutrophils were analyzed in RM-9 tumors. Tumors were harvested at various time points (0, 6, 12, 24, 48, and 96 h) after focal irradiation with 15 Gy. Tumor tissue lysates were analyzed using a cytokine array kit. Although significant increases in G-CSF, IL-1β, and KC levels were observed in the RT-Ns are involved in the therapeutic response to RT. RM-9-bearing C57BL/6 mice were irradiated (▲ and △) with 15 Gy or nonirradiated (• and ○) and treated with anti-Ly-6G (aLy-6G) mAb (△ and ○) or isotype control (▲ and •). Each point includes an average of five mice per experimental group; bars represent SD. Similar results were obtained from three independent experiments. Analysis of differences was performed by two-way ANOVA (*P < 0.05). Cont, control; Rad, irradiation.
irradiated tumor within 48 h (Fig. 5A) , only the G-CSF increase was confirmed by ELISA ( Fig. 5B and Fig. S8 A and B) . These results suggest that higher levels of G-CSF in the tumor contribute to the infiltration of RT-Ns.
The Concurrent Use of RT and G-CSF Increases ROS Production by RT-Ns and Enhances the Antitumor Activity of RT. We next hypothesized that the exogenous administration of G-CSF should further increase the production of ROS by activating neutrophils in tumors, hence enhancing the efficacy of RT. To test this hypothesis, we evaluated ROS production by RT-Ns after G-CSF administration. Tumor tissues were obtained 24 h after irradiation with 15 Gy and injection of G-CSF. CD11b + Gr-1 high+ cells were assessed by flow cytometry following staining with dihydrorhodamine 123 as previously described (25) . ROS production by RT-Ns [mean fluorescence intensity (MFI) of 57 and 74] was enhanced by RT and further increased by G-CSF (MFI of 91) (Fig. 6A) .
To analyze the effects of RT combined with G-CSF, oxidative damage and apoptosis were assessed in tumor tissue by flow cytometric analysis with TUNEL (Fig. 4) . The number of 8-OHdG + and 4-HNE + cells was increased in tumors from mice treated with both RT and G-CSF compared with mice treated with RT alone (8-OHdG: from 63.6 to 81.5%, 4-HNE: from 79.3 to 89.2%) (Fig. 6 B-E) . No significant difference (P > 0.05) was noted using 8-OHdG, but a difference (P < 0.05) in the percentage of 4-HNE + cells was observed between mice treated with G-CSF alone and untreated mice (8-OHdG: 27.7% and 27.9%, 4-HNE: 27.9% and 48.0%) (Fig. 6 B-E) . In addition, TUNEL + cells were increased in tumors from mice receiving combined treatment compared with those mice treated with RT alone (from 16.0 to 25.4%). Nevertheless, the difference between the mice treated with G-CSF alone and untreated mice (8.9% and 4.5%) was not statistically significant (P > 0.05). This result confirms that the observed increase in the efficacy of RT as a result of concurrent administration of G-CSF is mediated by increased oxidative damage and apoptosis.
Concurrent G-CSF and RT Lead to Decreased Tumor Growth Because of Higher ROS Production by RT-Ns. The efficacy of RT combined with G-CSF was evaluated in RM-9, 4T1, and EG7 tumorbearing mice. Tumor growth was inhibited significantly in groups receiving combination therapy compared with the control mice receiving RT alone (Fig. 7A and Fig. S9 A and B) . The results suggest that the antitumor activity of RT can be augmented by concurrent administration of G-CSF.
We next investigated the contribution of ROS and CD8 + cells to the therapeutic effect of RT and G-CSF. We also determined whether the RT-N-induced therapeutic effect could be abolished by depleting CD8
+ cells using an anti-CD8 mAb. RM-9 tumor grafts grew faster when neutrophils, CD8
+ cells, and ROS were depleted by anti-Ly-6G mAb, anti-CD8 mAb, and DPI, respectively (Fig. 7B ).
These results demonstrate that combining RT with G-CSF therapy is likely mediated by ROS produced from G-CSFstimulated RT-Ns. Furthermore, this increased therapeutic efficacy requires CD8 + cells. Therefore, increased ROS-mediated tumor death likely leads to more robust presentation of tumor antigens, and eventually to the downstream generation of tumor-specific CTLs.
G-CSF Enhances the RT-Mediated Production of Tumor-Specific CTLs.
Tumor RT has been implicated in initiating antigen presentation by dying cells, priming tumor-specific CTLs, and inducing an adaptive antitumor immune response enhancing therapeutic efficacy (26) (27) (28) (29) . We hypothesized that the increased antitumor efficacy of RT observed during the coadministration of G-CSF might be linked to an improved RT-mediated adaptive tumorspecific immune response. We therefore investigated whether tumor-specific CTLs were increased by G-CSF-mediated ROS production by RT-Ns. To evaluate tumor-specific CTL production, we quantified ovalbumin (OVA)-tetramer
+ cells in an EG7 tumor model (EL4 transduced to express OVA) by flow cytometry.
Lymphocytes isolated from the draining lymph nodes (DLNs) and tumor tissues were evaluated for the presence of an OVAspecific CTL population by staining cells with the OVA/H-2 (B) RM-9-bearing C57BL/6 mice were irradiated (▲, △, and ■) with 15 Gy or unirradiated (•, ○, and □) and treated with anti-Ly-6G mAb (○ and △), isotype control (•, ▲, □, and ■) or DPI (□ and ■). Similar results were obtained from two independent experiments. Analysis of differences was performed by two-way ANOVA (*P < 0.05).
elevated in DLNs (from 0.2 to 0.8%) and tumor tissues (from 0.2 to 1.3%) of EG7-bearing mice treated with RT compared with the frequencies of untreated mice (Fig. 8 A and B) . The frequency of the OVA-tetramer +
CD8
+ cells was further elevated in DLNs (2.7%) and tumor tissues (3.7%) of mice receiving concurrent administration of RT and G-CSF compared with mice treated with either RT or G-CSF alone.
We next investigated the role of RT-Ns and ROS in mice treated with both G-CSF and RT. The frequencies of the OVA-tetramer +
+ cells were amplified in DLNs (from 0.6 to 1.3%) and tumor tissues (from 2.3 to 6.8%) after combination therapy when compared with the control and RT-alone groups ( Fig.  8 C and D) . In addition, depletion of RT-Ns or ROS led to a decrease in OVA-tetramer
+ cells in DLNs (0.8% or 0.4%) and tumors (4.2% or 2.8%) after combination therapy (Fig. 8 C and D) .
These findings suggest that G-CSF can amplify the adaptive tumor-specific immune response initiated by RT; this amplification may be mediated by ROS production by the G-CSFstimulated RT-Ns.
Discussion
The major findings that emerge from our study are as follows: (i) Focal tumor RT leads to the early recruitment of RT-Ns; (ii) RT-Ns increase their production of ROS compared with Control-Ns, which originally reside in the tumor, and this increased ROS leads to oxidative damage, apoptosis of tumor cells, and tumor shrinkage; and (iii) G-CSF can activate RT-Ns leading to increased ROS-mediated damage, tumor cell apoptosis, and the subsequent activation of tumor-specific CTLs.
RT-Ns may have characteristics similar to those observed in normal tissues during sterile inflammation. This study demonstrated that RT leads to the transient (within 24 h) infiltration of neutrophils into the tumor. Although the mechanisms leading to neutrophilic infiltration have not been defined, it is likely that the DAMPs released by tumor or stromal cells after RT may be responsible for the early recruitment of RT-Ns (2, 30, 31) . In accordance with this finding, other studies have reported the transient infiltration of neutrophils into normal tissues within 24 h after irradiation (12, 13). The ROS produced by neutrophils responsible for tissue damage during sterile inflammation have also been observed in mouse models of ischemia (24) .
RT-Ns, as demonstrated here, are an example of the antitumor N1 behavior of TANs and confirm previous observation that after TGF-β blockade, neutrophils acquire an antitumor phenotype (i.e., protumor N2 cells become antitumor N1 cells) (7). Fridlender et al. (7) also showed that the antitumor activity of N1 TANs is mediated by ROS/H 2 O 2 . It has been reported that a lack of IFN-β leads to the accumulation of increased protumor N2 neutrophils in tumors, resulting in the promotion of tumor growth as previously reported (8, 32) . Conversely, increased IFN-β induces the antitumor N1 phenotype (33) . It has also been demonstrated that TANs in early-stage human lung cancer are more cytotoxic to tumor cells (9) compared with TANs in larger and more advanced tumors (34) .
The origins of RT-Ns may differ from the origins of antitumor N1s reported by Fridlender et al. (7) (Fig. S10) . The effect of RT-Ns may therefore be secondary to recruitment rather than a phenotypic polarization of TANs.
G-CSF up-regulates the expression of antitumor neutrophil markers, such as ICAM1 and TNF-α, and promotes the formation of neutrophil extracellular traps (NETs) (33, 35, 36) . As In contrast, an antitumor effect was observed when RT was delivered in limited fractions (45) . This observation suggests that early influx of RT-N may not occur after delivering repeated doses of RT, highlighting the importance of developing treatment regimens to amplify the infiltration of TANs immediately after RT.
Although many studies have shown that RT induces tumorspecific immune responses (26) (27) (28) (29) 46) , our study demonstrates that the generation of tumor-specific CTLs (CD8 + OVA-tetramer + cells) is increased by the combination of RT and G-CSF. In addition, we demonstrated that ROS produced by G-CSF-stimulated RT-Ns are involved in the amplification of tumor-specific CTLs. Therefore, G-CSF might be essential in initiating an RT-induced adaptive immune response. Although it is unclear whether the G-CSF-mediated increase in the antitumor CTL response is mediated by RT-Ns, we presume that the dead cells induced by ROS-producing RT-Ns stimulate tumor immune responses by inducing sterile infiltration in which dendritic cells become more effective (47) . Singhal et al. (48) reported that a subset of TANs exhibited characteristics of both neutrophils and antigen-presenting cells in early-stage human lung cancer. Lim et al. (49) recently showed that the chemokine CXCL12 produced by neutrophils provides chemotactic haptotactic signals for the efficient recruitment of CTLs into sites of infection. Neutrophils can guide influenza-specific CTLs into the airways. Therefore, RT-Ns likely play a critical role in the amplification of G-CSF-mediated, RT-induced, tumor-specific CTL responses.
In conclusion, our studies demonstrate that RT can change the immune profile of the tumor microenvironment and lead to the transient infiltration of antitumor RT-Ns into tumor tissue. Our studies further support the hypothesis that a combination of RT G-CSF enhances the tumor-specific adaptive immune response at both local and distal sites.
Materials and Methods
A full discussion of experimental procedures is available in SI Materials and Methods.
Animals. Male C57BL/6 mice and female BALB/c mice, between 6 and 8 wk of age, were obtained from Taconic. All animal protocols were approved by the Institutional Animal Care and Use Committee of the University of Texas Southwestern Medical Center. This study was performed in strict accordance with the recommendations in the guidelines from the NIH.
Cell Culture. RM-9 prostate carcinoma was cultured in DMEM, and 4T1 mammary carcinoma and EG7 thymoma (EL4 transduced to express OVA) were cultured in RPMI-1640 supplemented with 10% (vol/vol) FCS, 2 mmol/L L-glutamine, 0.05 mmol/L 2-mercaptoethanol, Hepes, penicillin, and streptomycin. Cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 .
Local Irradiation. The right leg with the target tumor was gently pulled out of the syringe hole, and the tumor was irradiated once with 15 Gy for RM-9 and 4T1 and with 1.3 Gy for EG7. Different tumors were given different doses according to their radiosensitivities (Fig. S1 ). Doses were delivered in a single fraction using a dedicated X-ray irradiator (X-RAD 320; Precision X-Ray, Inc.) with a 2-cm collimator. The device was operated at 250 kV and 1 mA, producing a dose rate of 1.27 Gy·min Days after tumor irradiation * * * Fig. 7 . G-CSF augments the antitumor RT-N response in tumor-bearing mice. G-CSF was injected s.c. for 4 consecutive days, starting on the day of RT administration for RM-9-, 4T1-, and EG7-bearing mice. (A) RM-9-bearing mice were irradiated (▲ and △) with 15 Gy or nonirradiated (• and ○) and treated with s.c. injection of G-CSF (△ and ○) or PBS (▲ and •). (B) RM-9-bearing mice were irradiated with 15 Gy either alone or in combination with anti-Ly-6G mAb, anti-CD8 mAb, DPI, and G-CSF. Similar results were obtained from three independent experiments. Analysis of differences was performed by two-way ANOVA (*P < 0.05).
